E
Iovance Biotherapeutics, Inc. IOVA
$2.45 -$0.08-3.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -14.99% -2.82% 32.50% 26.56% 8.85%
Total Depreciation and Amortization 9.89% 11.69% 20.31% 12.89% 38.55%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -12.96% 42.69% 191.99% 92.19% 63.65%
Change in Net Operating Assets 123.74% 45.84% -419.47% -326.10% -237.50%
Cash from Operations 31.48% 15.20% 12.71% 29.86% -4.77%
Capital Expenditure -1,588.01% -48.91% -18.11% 36.04% 95.36%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -100.00% 100.00% 100.00%
Divestitures -- -- -- -- --
Other Investing Activities -47.61% 140.32% 140.03% 35.45% -34.68%
Cash from Investing -65.58% 114.23% 132.50% 38.24% 125.65%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -91.07% -24.87% 177.79% -76.26% 11,500.68%
Repurchase of Common Stock 49.60% -20.06% -373.12% -1,556.20% -232.23%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -91.34% -25.96% 140.02% -79.31% 14,809.76%
Foreign Exchange rate Adjustments 691.20% 203.46% -138.99% 162.87% 96.68%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -141.95% 237.58% 68.27% -271.22% 137.28%